This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

The Real Story: First-Quarter Report Card

In my debut column for TheStreet.com at the beginning of the year, I wrote: "The purpose of this column is to help you increase your investment returns by selectively going against the consensus."

I knew that contrarian picks would surely raise some eyebrows and touch some nerves, as some of the feedback proved (see below).

But I remain convinced that one of the best ways to make money in the market is to zig when others are zagging.

A review of the performance of my first-quarter stock picks bears this out. Over the past three months, I have recommended six longs and six shorts. In total and broken down into longs and shorts, they have beaten the S&P 500, as the accompanying table indicates.

(Results do not include Wednesday's long recommendation of Movado (MOV), although the stock was up more than 3% early Friday after Jim Cramer echoed my bullish comments on "Mad Money" Thursday evening.)

Results are based on closing prices on the day the recommendation was made.

If you bought and sold every one of The Real Story's recommendations on the day they were made, you'd be sitting on a 2.6% gain vs. a 0.4% average gain if you bought or shorted the S&P 500 on those same days.

Keep in mind, The Real Story portfolio is a diverse group of stocks that includes technology, healthcare, retail, utilities, industrials, real estate, financials, restaurants and media. In my opinion there is less risk in that vs. simply owning the S&P 500, as the group is divided evenly between longs and shorts.

The long positions are up 4.2% vs. 1.6% if you bought the S&P on the same day as each of the various recommendations.

The shorts are in the black by 1.8%, even while the S&P has risen by 0.9%.



The Real Story So Far
Beating the S&P, long and short
Stock Story date Recommendation Last * Profit Percentage
LAMR 1/5 Short 52.40 -5.97 -12.9%
BJ 1/10 Short 31.69 -1.99 -6.7%
APPX 1/19 Short 28.25 9.18 24.5% closed 3/9/06
PFCB 1/25 Short 48.83 1.46 2.9%
WBS 1/31 Buy 48.49 1.39 3.0%
ENMC 2/8 Buy 5.15 -0.55 -9.6%
SUNW 2/15 Buy 5.15 0.83 19.2%
ADBE 2/27 Short 36.33 2.86 7.3% closed 3/23/06
ELN 3/6 Buy 14.76 2.06 16.2%
SCG 3/10 Buy 39.51 -0.56 -1.4%
BOOM 3/14 Buy 35.77 2.83 8.6%
JOE 3/23 Short 61.75 -0.80 -1.8%
Real Story Portfolio 2.6%
* as of close 3/30
Source: Thomson Financial

The biggest winner was a recommended short of American Pharmaceutical Partners (APPX) on Jan. 19. The position was closed on March 9 for a 24.5% gain. We also currently have a 21.5% winner in Sun Microsystems (SUNW). I'm still looking for a $6 price target on Sun. Investors are also looking at double-digit gains in Elan (ELN), while Dynamic Materials (BOOM - Get Report) is up over 9%.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,416.85 +225.48 1.31%
S&P 500 2,021.25 +19.09 0.95%
NASDAQ 4,683.4070 +45.4130 0.98%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs